<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">propranolol </span>
   <span class="font16">Propranolol </span>
   <span class="font15">treatment </span>
   <span class="font14">patients </span>
   <span class="font13">portal </span>
   <span class="font13">{border-style </span>
   <span class="font13">hypertension </span>
   <span class="font13">migraine </span>
   <span class="font13">px;} </span>
   <span class="font13">#ffffff;} </span>
   <span class="font12">used </span>
   <span class="font12">compared </span>
   <span class="font12">Med </span>
   <span class="font12">anxiety </span>
   <span class="font12">study </span>
   <span class="font12">trial </span>
   <span class="font12">cardiovascular </span>
   <span class="font12">effect </span>
   <span class="font12">essential </span>
   <span class="font12">management </span>
   <span class="font12">CI: </span>
   <span class="font12">associated </span>
   <span class="font12">beta-blockers </span>
   <span class="font12">effective </span>
   <span class="font12">myocardial </span>
   <span class="font11">digoxin </span>
   <span class="font11">use </span>
   <span class="font11">&amp;lt; </span>
   <span class="font11">drugs </span>
   <span class="font11">efficacy </span>
   <span class="font11">meta-analysis </span>
   <span class="font11">pediatric </span>
   <span class="font11">px; </span>
   <span class="font11">reduction </span>
   <span class="font11">safety </span>
   <span class="font11">variceal </span>
   <span class="font11">vs. </span>
   <span class="font11">{font-family </span>
   <span class="font11">Black </span>
   <span class="font11">Clin </span>
   <span class="font11">James </span>
   <span class="font11">Kim </span>
   <span class="font11">blockade </span>
   <span class="font11">drug </span>
   <span class="font11">effects </span>
   <span class="font11">font-size </span>
   <span class="font11">mortality </span>
   <span class="font11">prophylaxis </span>
   <span class="font11">propranolol, </span>
   <span class="font11">review </span>
   <span class="font11">therapy </span>
   <span class="font11">However, </span>
   <span class="font11">Neurology </span>
   <span class="font11">Sir </span>
   <span class="font11">angina </span>
   <span class="font11">beneficial </span>
   <span class="font11">beta- </span>
   <span class="font11">conditions. </span>
   <span class="font11">controlled </span>
   <span class="font11">disorder </span>
   <span class="font11">double; </span>
   <span class="font11">headache </span>
   <span class="font11">heart </span>
   <span class="font11">indications </span>
   <span class="font11">medications </span>
   <span class="font11">randomized </span>
   <span class="font11">significantly </span>
   <span class="font11">studies </span>
   <span class="font10">.). </span>
   <span class="font10">Ann </span>
   <span class="font10">Gastroenterol </span>
   <span class="font10">Indian </span>
   <span class="font10">Lee </span>
   <span class="font10">Moreover, </span>
   <span class="font10">Neurol </span>
   <span class="font10">beta-blocker </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cardiac </span>
   <span class="font10">caused </span>
   <span class="font10">combination </span>
   <span class="font10">conditions </span>
   <span class="font10">conducted </span>
   <span class="font10">hypertension, </span>
   <span class="font10">hyperthyroidism, </span>
   <span class="font10">including </span>
   <span class="font10">infarction </span>
   <span class="font10">patient </span>
   <span class="font10">placebo </span>
   <span class="font10">primary </span>
   <span class="font10">propranolol. </span>
   <span class="font10">randomized, </span>
   <span class="font10">results </span>
   <span class="font10">role </span>
   <span class="font10">safe </span>
   <span class="font10">solid; </span>
   <span class="font10">stress </span>
   <span class="font10">supraventricular </span>
   <span class="font10">surgery </span>
   <span class="font10">symptoms </span>
   <span class="font10">therapeutic </span>
   <span class="font10">treat </span>
   <span class="font10">tremors </span>
   <span class="font10">versus </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">âˆ’., </span>
   <span class="font10">(.% </span>
   <span class="font10">.%, </span>
   <span class="font10">Academy </span>
   <span class="font10">American </span>
   <span class="font10">Beta-blockers </span>
   <span class="font10">Clinical </span>
   <span class="font10">Cochrane </span>
   <span class="font10">EVL </span>
   <span class="font10">Efficacy </span>
   <span class="font10">Further, </span>
   <span class="font10">Headache </span>
   <span class="font10">OR: </span>
   <span class="font10">Rev </span>
   <span class="font10">SVT </span>
   <span class="font10">Treatment </span>
   <span class="font10">World </span>
   <span class="font10">acute </span>
   <span class="font10">anxiety, </span>
   <span class="font10">blood </span>
   <span class="font10">bold </span>
   <span class="font10">cirrhosis </span>
   <span class="font10">considered </span>
   <span class="font10">courier; </span>
   <span class="font10">decreasing </span>
   <span class="font10">developed </span>
   <span class="font10">disorders </span>
   <span class="font10">em; </span>
   <span class="font10">endoscopic </span>
   <span class="font10">group </span>
   <span class="font10">include </span>
   <span class="font10">infantile </span>
   <span class="font10">led </span>
   <span class="font10">memories </span>
   <span class="font10">noncardiovascular </span>
   <span class="font10">nonselective </span>
   <span class="font10">peripheral </span>
   <span class="font10">prescribed </span>
   <span class="font10">preventing </span>
   <span class="font10">prevention </span>
   <span class="font10">primidone </span>
   <span class="font10">pt;} </span>
   <span class="font10">quality </span>
   <span class="font10">receiving </span>
   <span class="font10">receptor </span>
   <span class="font10">reduce </span>
   <span class="font10">reduced </span>
   <span class="font10">reducing </span>
   <span class="font10">reported </span>
   <span class="font10">shown </span>
   <span class="font10">topiramate, </span>
   <span class="font10">tremors, </span>
   <span class="font10">varices </span>
  </p>
 </body>
</html>
